Cargando…

Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms: The NOVARA Score, a Multicentre Retrospective Study

Rectal neuroendocrine tumors (r-NETs) are rare tumors with overall good prognosis after complete resection. However, there is no consensus on the extension of lymphadenectomy or regarding contraindications to extensive resection. In this study, we aim to identify predictive factors that correlate wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ricci, Angela Dalia, Pusceddu, Sara, Panzuto, Francesco, Gelsomino, Fabio, Massironi, Sara, De Angelis, Claudio Giovanni, Modica, Roberta, Ricco, Gianluca, Torchio, Martina, Rinzivillo, Maria, Prinzi, Natalie, Rizzi, Felice, Lamberti, Giuseppe, Campana, Davide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836953/ https://www.ncbi.nlm.nih.gov/pubmed/35160165 http://dx.doi.org/10.3390/jcm11030713

Ejemplares similares

Management of Functional Pancreatic Neuroendocrine Neoplasms
por: Magi, Ludovica, et al.
Publicado: (2023)

Perioperative Chemotherapy in Poorly Differentiated Neuroendocrine Neoplasia of the Bladder: A Multicenter Analysis
por: Lamberti, Giuseppe, et al.
Publicado: (2020)

The Antiproliferative Activity of High-Dose Somatostatin Analogs in Gastro-Entero-Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis
por: Panzuto, Francesco, et al.
Publicado: (2022)

Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet)
por: Panzuto, F., et al.
Publicado: (2020)

Effect of Neuroendocrine Neoplasm Treatment on Human Reproductive Health and Sexual Function
por: Zamponi, Virginia, et al.
Publicado: (2022)

Role of [(18)F]FDG PET/CT in the management of G1 gastro-entero-pancreatic neuroendocrine tumors
por: Magi, Ludovica, et al.
Publicado: (2022)

Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence?
por: Massironi, Sara, et al.
Publicado: (2022)

Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET)
por: Lamberti, Giuseppe, et al.
Publicado: (2023)

Comparison of Endoscopic Techniques in the Management of Type I Gastric Neuroendocrine Neoplasia: A Systematic Review
por: Panzuto, Francesco, et al.
Publicado: (2021)

Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms
por: Panzuto, Francesco, et al.
Publicado: (2017)

Usefulness of 68-Gallium PET in Type I Gastric Neuroendocrine Neoplasia: A Case Series
por: Rinzivillo, Maria, et al.
Publicado: (2022)

Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors
por: Pusceddu, Sara, et al.
Publicado: (2022)

Landscape and Future Perspectives of Immunotherapy in Neuroendocrine Neoplasia
por: Maggio, Ilaria, et al.
Publicado: (2020)

The Increasing Incidence of Neuroendocrine Neoplasms Worldwide: Current Knowledge and Open Issues
por: Rossi, Roberta Elisa, et al.
Publicado: (2022)

The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidence
por: Pusceddu, Sara, et al.
Publicado: (2020)

Impact of Diabetes and Metformin Use on Enteropancreatic Neuroendocrine Tumors: Post Hoc Analysis of the CLARINET Study
por: Pusceddu, Sara, et al.
Publicado: (2021)

Differential Diagnosis and Management of Diarrhea in Patients with Neuroendocrine Tumors
por: Pusceddu, Sara, et al.
Publicado: (2020)

Utility of histopathological revision in the management of gastro-entero-pancreatic neuroendocrine neoplasia
por: Marasco, Matteo, et al.
Publicado: (2023)

Therapeutic Challenges for Gastric Neuroendocrine Neoplasms: Take It or Leave It?
por: Cavalcoli, Federica, et al.
Publicado: (2023)

Beyond Traditional Morphological Characterization of Lung Neuroendocrine Neoplasms: In Silico Study of Next-Generation Sequencing Mutations Analysis across the Four World Health Organization Defined Groups
por: Centonze, Giovanni, et al.
Publicado: (2020)

Myeloid and T-Cell Microenvironment Immune Features Identify Two Prognostic Sub-Groups in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms
por: Centonze, Giovanni, et al.
Publicado: (2021)

Small nonfunctional pancreatic neuroendocrine neoplasms: Time for a step-up treatment approach?
por: Rimbaş, Mihai, et al.
Publicado: (2022)

Multidisciplinary Approach to the Diagnosis of Occult Primary Neuroendocrine Neoplasm: A Clinical Challenge
por: Rossi, Roberta Elisa, et al.
Publicado: (2023)

Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges
por: Andrini, Elisa, et al.
Publicado: (2022)

An Update on Appendiceal Neuroendocrine Tumors
por: Andrini, Elisa, et al.
Publicado: (2023)

Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial
por: Corti, Francesca, et al.
Publicado: (2023)

Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches
por: Lania, Andrea, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on the activity of the Radiological Emergency Department: the experience of the Maggiore della Carità Hospital in Novara
por: Garlisi, C., et al.
Publicado: (2021)

Clinical and Forensic Aspects of the Management of Child Abuse: The Experience of the Paediatric Emergency Department in Novara, North-West Italy
por: Puppi, Micol, et al.
Publicado: (2023)

Prophylactic cholecystectomy is not mandatory in patients candidate to the resection for small intestine neuroendocrine neoplasms: a propensity score-matched and cost-minimization analysis
por: Ingaldi, Carlo, et al.
Publicado: (2021)

Endoscopic techniques for diagnosis and treatment of gastro-entero-pancreatic neuroendocrine neoplasms: Where we are
por: Rossi, Roberta Elisa, et al.
Publicado: (2022)

Clinical Challenges in the Management of Neuroendocrine Tumors
por: Panzuto, Francesco
Publicado: (2021)

Nuclear Medicine and Radiological Imaging of Pancreatic Neuroendocrine Neoplasms: A Multidisciplinary Update
por: Prosperi, Daniela, et al.
Publicado: (2022)

Critical Care Surge Capacity to Respond to the COVID-19 Pandemic in Italy: A Rapid and Affordable Solution in the Novara Hospital
por: Cammarota, Gianmaria, et al.
Publicado: (2020)

Impact of Vitamin D Deficiency on Tumor Aggressiveness in Neuroendocrine Neoplasms
por: Albertelli, Manuela, et al.
Publicado: (2023)

Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine/Non-neuroendocrine Neoplasms
por: La Rosa, Stefano
Publicado: (2021)

Application of FLIC model to predict adverse events onset in neuroendocrine tumors treated with PRRT
por: Scalorbi, Federica, et al.
Publicado: (2021)

CT-based radiomics for prediction of therapeutic response to Everolimus in metastatic neuroendocrine tumors
por: Caruso, Damiano, et al.
Publicado: (2022)

Primary Cerebellar Neuroendocrine Tumors: Chimeras or Real Entities? A Case Report with a 6-Year Follow-Up
por: Vernieri, Claudio, et al.
Publicado: (2016)

Imaging presentation of pancreatic neuroendocrine neoplasms
por: Ciaravino, Valentina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5f25915iss71givvmqe5l9kor8